Literature DB >> 12682711

Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats.

Pat Bauco1, Pierre-Paul Rompré.   

Abstract

RATIONALE: Lewis (LEW) and Fischer (F344) rats exhibit marked differences in appetitive and consummatory responses to numerous drugs, including psychostimulants. Neurotensin (NT) produces psychostimulant-like actions, which sensitize with repeated exposure, and neuroleptic-like actions; effects that are dependent on the site of microinjection. The aim of the present experiments was to assess the behavioral sensitivity of these two strains of rats to NT receptor activation.
METHODS: In expt 1, locomotor activity was assessed on alternate days following an ICV injection of NT, [ d-Tyr(11)]neurotensin ( d-NT; 18 nmol/10 microl), or vehicle (days 1, 3, 5, and 7) in independent groups of LEW and F344 rats. On day 14, locomotor activity was assessed in all rats following an injection of d-amphetamine (1 mg/kg, IP). In expt 2, activity was assessed following injection into the ventral tegmental area of NT, or d-NT, (2.5 microg/hemisphere) or into the nucleus accumbens (2.5 and 5.0 microg/hemisphere). RESULTS. Repeated ICV injections of NT, or d-NT, produced differential behavioral effects in the two strains of rats on days 1-7; activity was initially suppressed in LEW, but less so in F344 rats, following NT. In F344, but not in LEW rats, d-NT produced a significant increase in activity. Neurotensin and d-NT sensitized LEW rats to amphetamine-induced ambulatory and non-ambulatory activity. Except for vertical activity, this effect was weaker or in the opposite direction in F344 rats. When injected into the ventral tegmental area, NT produced an increase in locomotor activity in both strains, an effect that was greater in F344 than LEW rats with d-NT. In the nucleus accumbens, NT marginally decreased activity in both strains, while d-NT produced a significant increase in F344 but not in LEW rats.
CONCLUSIONS: These results provide empirical evidence that endogenous NT neurotransmission within limbic circuitry differs in F344 and LEW rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682711     DOI: 10.1007/s00213-003-1436-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  57 in total

Review 1.  Incentive-sensitization and addiction.

Authors:  T E Robinson; K C Berridge
Journal:  Addiction       Date:  2001-01       Impact factor: 6.526

2.  The neurotensin receptor antagonist, SR48692, attenuates the expression of amphetamine-induced behavioural sensitisation in mice.

Authors:  F G Costa; R Frussa-Filho; L F Felicio
Journal:  Eur J Pharmacol       Date:  2001-09-28       Impact factor: 4.432

3.  The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes.

Authors:  I Dubuc; J Costentin; J P Terranova; M C Barnouin; P Soubrié; G Le Fur; W Rostène; P Kitabgi
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

4.  SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission.

Authors:  R Steinberg; P Brun; M Fournier; J Souilhac; D Rodier; G Mons; J P Terranova; G Le Fur; P Soubrié
Journal:  Neuroscience       Date:  1994-04       Impact factor: 3.590

5.  Behavior genetic investigation of the relationship between spontaneous locomotor activity and the acquisition of morphine self-administration behavior.

Authors:  E. Ambrosio; S.R. Goldberg; G.I. Elmer
Journal:  Behav Pharmacol       Date:  1995-04       Impact factor: 2.293

6.  Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains.

Authors:  M Lepore; X Liu; V Savage; D Matalon; E L Gardner
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

7.  Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats.

Authors:  Z H Meng; D L Feldpaush; K M Merchant
Journal:  Brain Res Mol Brain Res       Date:  1998-10-30

8.  Neurotensin analogs [D-TYR11] and [D-PHE11]neurotensin resist degradation by brain peptidases in vitro and in vivo.

Authors:  F Checler; J P Vincent; P Kitabgi
Journal:  J Pharmacol Exp Ther       Date:  1983-12       Impact factor: 4.030

9.  The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations.

Authors:  D L Feldpausch; L M Needham; M P Stone; J S Althaus; B K Yamamoto; K A Svensson; K M Merchant
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

10.  Relationships between structure and duration of neurotensin's central action: emergence of long acting analogs.

Authors:  F B Jolicoeur; S St-Pierre; C Aubé; R Rivest; M A Gagné
Journal:  Neuropeptides       Date:  1984-11       Impact factor: 3.286

View more
  3 in total

1.  The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion.

Authors:  Ricardo Cáceda; Elisabeth B Binder; Becky Kinkead; Charles B Nemeroff
Journal:  Schizophr Res       Date:  2011-11-21       Impact factor: 4.939

2.  Repeated ventral midbrain neurotensin injections sensitize to amphetamine-induced locomotion and ERK activation: A role for NMDA receptors.

Authors:  David Voyer; Daniel Lévesque; Pierre-Paul Rompré
Journal:  Neuropharmacology       Date:  2016-06-05       Impact factor: 5.250

3.  Ventral Midbrain NTS1 Receptors Mediate Conditioned Reward Induced by the Neurotensin Analog, D-Tyr[11]neurotensin.

Authors:  Khalil Rouibi; Poulomee Bose; Pierre-Paul Rompré; Richard A Warren
Journal:  Front Neurosci       Date:  2015-12-22       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.